효소결합면역흡착측정법(ELISA) 검사 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global enzyme-linked immunosorbent assay (ELISA) testing market size is expected to reach USD 6.38 Billion in 2034 from USD 3.37 Billion in 2025, growing at a CAGR of 7.35 during 2026-2034.The global enzyme-linked immunosorbent assay (ELISA) testing market is experiencing strong growth due to its widespread use in disease diagnosis and biomedical research. ELISA is a laboratory technique used to detect antibodies, antigens, and proteins in biological samples. It is commonly used in the diagnosis of infectious diseases, autoimmune disorders, and cancer biomarkers.

One of the major drivers of the market is the increasing demand for accurate and reliable diagnostic testing. Healthcare providers and research laboratories rely heavily on ELISA tests because they offer high sensitivity and specificity. Additionally, rising investments in biotechnology research and the development of advanced diagnostic technologies are boosting the market.

In the future, the ELISA testing market is expected to grow as demand for rapid and efficient diagnostic solutions increases worldwide. Advances in laboratory automation and multiplex testing technologies are likely to enhance testing efficiency. As global healthcare systems emphasize early disease detection and personalized medicine, ELISA testing will continue to play a crucial role in diagnostics and research.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Method

• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA

By Application

• Vaccine Development
• Immunology
• Diagnostics
• Toxicology
• Drug Monitoring & Pharmaceutical Industry
• Transplantation
• Infectious Diseases
• Cancer
• Protein Quantitation
• Others

By Technology

• Chemiluminescent
• Colorimetric
• Fluorescent

By End User

• Hospitals & Diagnostic Centers
• Research Laboratories

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer, Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott, Merck KGaA, BD, Bio-Techne Corporation, Enzo Biochem, Inc., RayBiotech, Inc., OriGene Technologies, Inc., Creative Diagnostics, MyBioSource, Inc., Abcam Limited, Elabscience Biotechnology Inc., GenScript Biotech Corporation, American Laboratory Products Company (ALPCO), BioMerieux

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Method
• 4.2. Direct ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Indirect ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sandwich ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Competitive ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccine Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Toxicology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Drug Monitoring & Pharmaceutical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Transplantation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Protein Quantitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Chemiluminescent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Colorimetric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Fluorescent Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals & Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Method
  • 8.2.2 By Application
  • 8.2.3 By Technology
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Method
  • 8.3.2 By Application
  • 8.3.3 By Technology
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Method
  • 8.4.2 By Application
  • 8.4.3 By Technology
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Method
  • 8.5.2 By Application
  • 8.5.3 By Technology
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Method
  • 8.6.2 By Application
  • 8.6.3 By Technology
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Bio-Rad LaboratoriesInc
  • 10.2.3 Danaher Corporation
  • 10.2.4 PerkinElmerInc
  • 10.2.5 Siemens Healthineers AG
  • 10.2.6 F. Hoffmann-La Roche Ltd
  • 10.2.7 Abbott
  • 10.2.8 Merck KGaA
  • 10.2.9 BD
  • 10.2.10 Bio-Techne Corporation
  • 10.2.11 Enzo BiochemInc
  • 10.2.12 RayBiotechInc
  • 10.2.13 OriGene TechnologiesInc
  • 10.2.14 Creative Diagnostics
  • 10.2.15 MyBioSourceInc
  • 10.2.16 Abcam Limited
  • 10.2.17 Elabscience Biotechnology Inc
  • 10.2.18 GenScript Biotech Corporation
  • 10.2.19 American Laboratory Products Company (ALPCO)
  • 10.2.20 BioMerieux